LDL Receptor-Related Protein 2 (Megalin) as a Target Antigen in Human Kidney Anti-Brush Border Antibody Disease
Christopher P. Larsen(Arkana Laboratories), Laurence H. Beck, Nidia Messias(Arkana Laboratories), Ivy A. Rosales(Harvard University), Daniel W. Wilkey(University of Louisville), L. Nicholas Cossey(Arkana Laboratories), Robert B. Colvin(Harvard University), Paige Coles(Boston University), A. Bernard Collins(Massachusetts General Hospital), David J. Salant(Boston University), Michael L. Merchant(University of Iowa), Josephine M. Ambruzs(Arkana Laboratories), Hong Ma(Boston University), Jon B. Klein(Canon (Japan)), Thomas D. Wooldridge, Patrick D. Walker(Arkana Laboratories), Claire Trivin-Avillach(Boston University)
Cited by 81
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology
|Kidney International|1993|1.5k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k